Holds one active US DMF for anagrelide, filing since 2015. Its 2026 FDA inspection closed as NAI, and its GMP is recognised in 20 markets.
Holds one active US DMF for anagrelide, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 20 markets.
Holds one active US DMF for anagrelide, filing since 2023. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 10 markets.
Holds one active US DMF for anagrelide, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF for anagrelide, filing since 2003. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
This page filters the worldwide Anagrelide manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for anagrelide and what filings they hold.
Chat with Fred, your AI analyst